←Back to Expert Scholars
Translational Medicine / 转化医学Iron Overload, Hemoglobinopathies
Elliott Vichinsky
MD
🏢UCSF Benioff Children's Hospital Oakland🌐USA
Director, Hematology/Oncology Program
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Elliott Vichinsky leads the Hematology/Oncology program at UCSF Benioff Oakland and has been central to the development of deferasirox and other chelators for thalassemia and sickle cell disease. He led pivotal North American trials. His work has transformed care for hemoglobinopathies.
Share:
🧪Research Fields 研究领域
thalassemia
sickle cell disease
iron chelation trials
deferasirox development
pediatric hematology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Elliott Vichinsky 的研究动态
Follow Elliott Vichinsky's research updates
留下邮箱，当我们发布与 Elliott Vichinsky（UCSF Benioff Children's Hospital Oakland）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment